| 51 |
30062227 | Potentiation of Insulin Signaling Contributes to Heart Failure in Type 2 Diabetes: A Hypothesis Supported by Both Mechanistic Studies and Clinical Trials. | 2018 Jun |
2 |
| 52 |
30115526 | Glycaemic control in native Kuwaiti Arab patients with type 2 diabetes. | 2018 Dec |
1 |
| 53 |
30264528 | Ethnic variations in the risk of hypoglycaemia among people with Type 2 diabetes prescribed insulins and/or sulfonylureas: a historical cohort study using general practice-recorded data. | 2018 Dec |
1 |
| 54 |
30327785 | Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions. | 2018 |
1 |
| 55 |
28083968 | First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment. | 2017 Sep |
1 |
| 56 |
28092788 | Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy. | 2017 Feb |
1 |
| 57 |
28093996 | Challenges Related to Glycemic Control in Type 2 Diabetes Mellitus Patients. | 2017 |
1 |
| 58 |
28111849 | Sulfonylurea challenge test in subjects diagnosed with type 1 diabetes mellitus. | 2017 Dec |
1 |
| 59 |
28295962 | Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest? | 2017 Sep |
1 |
| 60 |
28431776 | Gliclazide. | 2017 |
1 |
| 61 |
28456998 | New insights into antidiabetic drugs: Possible applications in cancer treatment. | 2017 Dec |
1 |
| 62 |
28556992 | Management of sulfonylurea-treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer. | 2017 Oct |
1 |
| 63 |
28587604 | KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment. | 2017 Jun 6 |
2 |
| 64 |
28880474 | β-Cell signalling and insulin secretagogues: A path for improved diabetes therapy. | 2017 Sep |
1 |
| 65 |
29049639 | Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes. | 2017 Oct 17 |
1 |
| 66 |
29108837 | Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries. | 2017 Nov |
1 |
| 67 |
31149195 | PATIENTS TREATED WITH INSULIN AND SULPHONYLUREA ARE AT INCREASED MORTALITY RISK AS COMPARED WITH THOSE TREATED WITH INSULIN PLUS METFORMIN. | 2017 Jul-Sep |
1 |
| 68 |
26547662 | Case-control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident stroke. | 2016 Feb |
1 |
| 69 |
26740120 | Metformin and pancreatic cancer: Is there a role? | 2016 Feb |
1 |
| 70 |
26811361 | Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea. | 2016 Apr 5 |
1 |
| 71 |
26822262 | Successful switch from insulin to oral sulfonylurea therapy in HNF1A-MODY Tunisian patient with the P291fsinsC mutation. | 2016 May |
1 |
| 72 |
26831749 | Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis. | 2016 Aug |
2 |
| 73 |
26881467 | Investigational insulin secretagogues for type 2 diabetes. | 2016 |
1 |
| 74 |
26921160 | Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes. | 2016 Jun |
1 |
| 75 |
26986544 | Hypoglycemia, diabetes therapies and driving categories in type 2 diabetes. | 2016 Jun |
1 |
| 76 |
26992707 | Capsule Commentary on Min et al., Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes: How to Escalate Therapy for Patients who Fail Sulfonylureas. | 2016 Jun |
1 |
| 77 |
27033559 | Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes. | 2016 Jun |
4 |
| 78 |
27175740 | Risk factors associated with treatment discontinuation and down-titration in type 2 diabetes patients treated with sulfonylureas. | 2016 Sep |
1 |
| 79 |
27327605 | Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43). | 2016 |
1 |
| 80 |
27329029 | Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea. | 2016 Jul |
1 |
| 81 |
27374266 | [Management of hyperglycemic/diabetic patient during and in the immediate follow-up of an acute coronary syndrome]. | 2016 Oct |
1 |
| 82 |
27513562 | Anti-Hyperglycemic Agents and New-Onset Acute Myocardial Infarction in Diabetic Patients with End-Stage Renal Disease Undergoing Dialysis. | 2016 |
1 |
| 83 |
27592478 | Evaluation, efficacy and tolerability of GlucoNovax tablet in type 2 diabetic patients. | 2016 Jul |
1 |
| 84 |
27640062 | Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. | 2016 Sep 18 |
1 |
| 85 |
27766795 | Reduction of Sulfonylurea with the Initiation of Basal Insulin in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Undergoing Long-Term Sulfonylurea-Based Treatment. | 2016 Dec |
4 |
| 86 |
31149081 | STUDY OF KCNJ11 GENE MUTATIONS IN ASSOCIATION WITH MONOGENIC DIABETES OF INFANCY AND RESPONSE TO SULFONYLUREA TREATMENT IN A COHORT STUDY IN EGYPT. | 2016 Apr-Jun |
1 |
| 87 |
24809622 | China type 2 diabetes treatment status survey of treatment pattern of oral drugs users | 2015 Mar |
1 |
| 88 |
25205223 | Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study. | 2015 Jan |
6 |
| 89 |
25325279 | Optimal candidates for the switch from glimepiride to sitagliptin to reduce hypoglycemia in patients with type 2 diabetes mellitus. | 2015 Mar 27 |
1 |
| 90 |
25483937 | Treatment of young patients with HNF1A mutations (HNF1A-MODY). | 2015 Apr |
1 |
| 91 |
25744824 | A red-shifted photochromic sulfonylurea for the remote control of pancreatic beta cell function. | 2015 Apr 7 |
1 |
| 92 |
25765720 | Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals. | 2015 Jun |
1 |
| 93 |
25767401 | Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial. | 2015 |
3 |
| 94 |
25796278 | [Sulfonylureas in today's blood glucose lowering therapy. New data on advantages and potential barriers of an "old" antidiabetic group]. | 2015 Mar 29 |
1 |
| 95 |
25812368 | [DPP-4 inhibitor]. | 2015 Mar |
1 |
| 96 |
25877689 | Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes. | 2015 Jul |
2 |
| 97 |
25893855 | The Novel Role of the Kidney in Diabetes Management: Sodium-Glucose Co-Transporter 2 Inhibitors. | 2015 Sep |
1 |
| 98 |
25962401 | Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy. | 2015 Oct |
1 |
| 99 |
26013675 | Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databases. | 2015 Jul |
1 |
| 100 |
26024708 | Insulinoma in a patient with type 2 diabetes mellitus. | 2015 |
2 |